Ticker Details
Tarsus Pharmaceuticals, Inc. Common Stock
IPO Date:	October 12, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.90 | 2.80%
Avg Daily Range (30 D):	$1.46 | 2.27%
Avg Daily Range (90 D):	$1.39 | 2.08%

Institutional Daily Volume
Avg Daily Volume:	.29M
Avg Daily Volume (30 D):	.52M
Avg Daily Volume (90 D):	.48M

Trade Size
Avg Trade Size (Sh.):	55
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	1,692
Avg Institutional Trade:	$3.11M
Avg Institutional Trade (30 D):	$4.12M
Avg Institutional Trade (90 D):	$3.86M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.33M
Avg Closing Trade (30 D):	$4.97M
Avg Closing Trade (90 D):	$4.79M
Avg Closing Volume:	76.42K

News

May 7, 2026 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: Not Specified

Mar 24, 2026 @ 5:06 PM Tarsus Pharma Stock Up 20% as Insider Sells $839K ... Source: Jonathan Ponciano

Oct 28, 2025 @ 9:00 PM Tarsus to Report Third Quarter 2025 Financial Resu... Source: Tarsus Pharmaceuticals, Inc.

Oct 27, 2025 @ 3:15 PM Capricorn Fund Loads Up on Phreesia (PHR) With a 4... Source: Cory Renauer

Oct 1, 2025 @ 5:00 PM Lyme Disease Market Growth Highlighted by Pipeline... Source: Delveinsight

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.16	$-.19	$-1.59
Diluted EPS	$-.16	$-.19	$-1.59
Revenue	$162.05M	$151.67M	$451.36M
Gross Profit	$152.66M
Net Income / Loss	$-6.97M	$-8.37M	$-66.42M
Operating Income / Loss	$-6.12M	$-7.98M	$-70.97M
Cost of Revenue	$9.4M
Net Cash Flow	$-82.01M	$70.92M	$88.82M
PE Ratio